IDT Biologika
Sustainability Report and Carbon Intensity Rankings
Is IDT Biologika doing their part?
Their DitchCarbon score is 45
IDT Biologika has a DitchCarbon Score of 45, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, which is a measure of the greenhouse gases emitted relative to its activity. A higher score would suggest a lower carbon intensity and a stronger commitment to reducing emissions.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
IDT Biologika is a company in the research and development sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
IDT Biologika, located in the United States, operates in a region with a low carbon intensity rating. This suggests that the company’s sustainability efforts are supported by the country’s relatively low reliance on carbon-intensive energy sources.
Unlock 30+ emissions data points on IDT Biologika
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on IDT Biologika
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
6.36%
...this company is doing 6.36% worse in emissions than the industry average.
Founded in 1921 and headquartered in Dessau-Roßlau, Germany, IDT Biologika operates in the research and development sector of the biopharmaceutical industry. The company specializes in the development, manufacture, and distribution of biologics for human and animal health, offering services globally with a strong presence in the United States. With a focus on vaccines, animal health, and pharmaceuticals, IDT Biologika is recognized for its advanced production capabilities and regulatory expertise in FDA- and EMA-inspected facilities.
emission intelligence's platform recommendations for IDT Biologika
IDT Biologika should undertake a thorough inventory of all Scope 1 emissions sources to identify and mitigate direct greenhouse gas emissions, which could potentially reduce their emissions by 15%.
Bad news, IDT Biologika hasn't committed to SBTi goals yet
IDT Biologika has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.